StonvexLoading…
StonvexStonvexStonvexCore line items from TOL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $2.15B | $10.97B | $7.54B | $4.60B |
Operating Income | $219.06M | $1.72B | $1.16B | $668.81M |
Net Income | $210.93M | $1.35B | $369.62M | $352.45M |
EPS (Diluted) | $2.19 | $13.49 | $3.73 | $3.50 |
Total Assets | $14.43B | $14.52B | $14.40B | $14.20B |
Total Liabilities | $6.01B | $6.23B | $6.29B | $6.23B |
Cash & Equivalents | $1.20B | $1.26B | $852.31M | $686.47M |
Free Cash Flow OCF − CapEx | $-11.59M | $1.03B | $254.02M | $-90.84M |
Shares Outstanding | 96.50M | 94.80M | 99.17M | 100.58M |